APA (7th ed.) Citation

Han, H. J., Jang, S., Dahye, R., Lee, H., Lee, J., Bae, E. J., . . . Suh, H. S. (2025, December). Analysis of the economically justifiable price of nirsevimab to prevent respiratory syncytial virus infection in Korea. Human Vaccines & Immunotherapeutics.

Chicago Style (17th ed.) Citation

Han, Hyun Jin, Semin Jang, Ryu Dahye, Haeseon Lee, Jiyeon Lee, Eun Jin Bae, Samira Soudani, and Hae Sun Suh. "Analysis of the Economically Justifiable Price of Nirsevimab to Prevent Respiratory Syncytial Virus Infection in Korea." Human Vaccines & Immunotherapeutics Dec. 2025.

MLA (9th ed.) Citation

Han, Hyun Jin, et al. "Analysis of the Economically Justifiable Price of Nirsevimab to Prevent Respiratory Syncytial Virus Infection in Korea." Human Vaccines & Immunotherapeutics, Dec. 2025.